Concepedia

Isabella Versteege

IV

11

Publications

2.1K

Citations

11

H-Index

1998

Active since

Affiliations

Inserm(Current)

Institut Curie

Johnson & Johnson (Netherlands)

Janssen (Netherlands)

Servier (France)

Isabella Versteege is an author at Inserm specializing in medicine, cell biology, and radiation oncology.

Top concepts

Publications per year

1998–2023

11

Publications

11

Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer

Isabella Versteege, Nicolas Sévenet, Julian Lange et al. · Nature · 1998 · 1.5K citations

, , +3

A key role of the hSNF5/INI1 tumour suppressor in the control of the G1-S transition of the cell cycle

Isabella Versteege, Souhila Medjkane, Danny Rouillard et al. · Oncogene · 2002 · 169 citations

, , +11

The Tumor Suppressor hSNF5/INI1 Modulates Cell Growth and Actin Cytoskeleton Organization

Souhila Medjkane, Eugene Novikov, Isabella Versteege et al. · Cancer Research · 2004 · 93 citations · Full text

Ad35.CS.01 - RTS,S/AS01 Heterologous Prime Boost Vaccine Efficacy against Sporozoite Challenge in Healthy Malaria-Naïve Adults

Christian F. Ockenhouse, Jason A. Regules, Donna Tosh et al. · PLoS ONE · 2015 · 93 citations · Full text

A Phase 1b Randomized, Controlled, Double-Blinded Dosage-Escalation Trial to Evaluate the Safety, Reactogenicity and Immunogenicity of an Adenovirus Type 35 Based Circumsporozoite Malaria Vaccine in Burkinabe Healthy Adults 18 to 45 Years of Age

Alphonse Ouédraogo, Alfred B. Tiono, Désiré Kargougou et al. · PLoS ONE · 2013 · 52 citations · Full text

Rows per page

1–5 of 11